Trial Buster
Pharmacologist Lisa Bero, PhD, answers our questions about industry bias in clincial trials.
University of California San Francisco
Give to UCSF
Nobel Prize Rockets Stem Cell Program to New Heights
Shinya Yamanaka's Nobel Prize for stem cell research brought fresh attention to something UCSF long ago sensed and seized: the promise of regeneration medicine for repairing or replacing damaged cells, tissues, and even whole organs.
Identity Theft: The Destructive Course of Behavioral Variant Frontotemporal Dementia
William Seeley maps the path of frontotemporal dementia through the brain, correlating specific damage with behavioral change. By studying the disease from self to circuits to cells, this visionary neurologist searches for inroads to treatment.
UCSF at Work in the World
A few of the many UCSF projects underway across the globe.
Improving Health By Our Own Devices
Five UCSF scientists – bioengineers Tejal Desai and Shuvo Roy, MD/PhD candidate Mozziyar Etemadi, microbiologist Joe DeRisi, and physician/surgeon Michael Harrison – trace their path toward five inventions that are changing the face of medicine.
